医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Dr. Andreas Amrein Joins Advanced Clinical to Lead Global Development and Expansion in APAC, Europe and Canada

2022年03月09日 AM08:52
このエントリーをはてなブックマークに追加


 

CHICAGO

Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to announce that Dr. Andreas Amrein has joined the Executive Team as Senior Vice President of Asia-Pacific (APAC) and Japan as well as Managing Director for Europe and Canada.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220308006375/en/

Dr. Andreas Amrein, Senior Vice President of Asia-Pacific (APAC) and Japan as well as Managing Director for Europe and Canada, Advanced Clinical (Photo: Business Wire)

Dr. Andreas Amrein, Senior Vice President of Asia-Pacific (APAC) and Japan as well as Managing Director for Europe and Canada, Advanced Clinical (Photo: Business Wire)

Dr. Amrein will be instrumental to the organization’s continued expansion and strengthening of Advanced Clinical’s current operations into the APAC region, which include offices in Singapore, Australia and Japan. He’ll also oversee development and expansion opportunities for additional locations across Europe and Canada, complementing the company’s existing footprint inclusive of 10 office locations in Europe as well as an office in Toronto, Canada.

With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies, including Fortune 100 companies (Novartis, Abbott and Shire) and dynamic start-ups.

“From my specialization in rapid commercial expansions, launches, transformations, partnerships and more across Asia and around the globe, I look forward to leveraging my knowledge to help Advanced Clinical further establish quality operations internationally,” said Dr. Amrein.

“We are excited to have Andreas on our team as we continue to expand into the APAC region and Japan,” said Julie Ross, President of Advanced Clinical. “Andreas will be instrumental in accelerating business growth as we diversify our global clinical programs and elevate our clinical strategy for the clients and patients we serve. After our successful entry into the region in 2021 combined with additional APAC office openings planned for 2022, Andreas will undoubtedly help elevate our presence across the APAC, European and Canadian regions as a global leader in clinical research, FSP and strategic resourcing services.”

About Advanced Clinical

Advanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of all those touched by clinical research – approaching each opportunity with foresight, character, resilience and innovation. Based on decades of experience, we help our clients achieve better outcomes by conducting candid conversations and anticipating potential issues through our customized solutions. Visit our website to learn more: www.advancedclinical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220308006375/en/

CONTACT

Stephanie Swanson

Senior Director of Global Marketing

P: (312) 572-6000

sswanson@advancedclinical.com

 

同じカテゴリーの記事 

  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
  • Masimo创始人兼首席执行官Joe Kiani将在智利举行的全球患者安全峰会上谈论人工智能